Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01634035 · ClinicalTrials.gov registry record
Correlation Between Glycated Hemoglobin and Mean Plasma Glucose in Hemodialysis Patients
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 159
- Enrollment target
NCT01634035: Completed study, sponsored by Northwell Health.
NCT01634035 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 159 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01634035 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 159 participants
- Enrollment target
Study Summary
The investigators are studying the correlation between Hba1c and the mean plasma glucose in diabetic hemodialysis patients.We are reviewing if HbA1c is a good clinical tool to assess glycemic control over a 3 months duration in hemodialysis patients
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2009-03 |
| Est. Completion | 2009-05 |
What the finished NCT01634035 record still lists
NCT01634035 is an observational study that tracks outcomes without assigning an intervention. The registered 159 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01634035 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01634035 about?
NCT01634035 is a clinical study titled "Correlation Between Glycated Hemoglobin and Mean Plasma Glucose in Hemodialysis Patients". The investigators are studying the correlation between Hba1c and the mean plasma glucose in diabetic hemodialysis patients.We are reviewing if HbA1c is a good clinical tool to assess glycemic control over a 3 months duration in hemodialysis patients
What is the current status of trial NCT01634035?
This trial is currently completed. The enrollment target is 159 participants. The study started on 2009-03. Estimated completion is 2009-05.
Who is sponsoring clinical trial NCT01634035?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05267626 · 159 participants · Phase 1
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- NCT06321575 · 159 participants · NA
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
- NCT06729151 · 159 participants
Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome
- NCT07023731 · 159 participants · Phase 1
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia